Concepedia

Author

Henri Sasmor

Ionis Pharmaceuticals (United States)

Also Known As

H M Sasmor, H Sasmor, H. SASMOR, H. Sasmor, HENRI SASMOR, Henri M. Sasmor, Henri Sasmor

42

Publications

3.5K

Citations

23

H-Index

53

Concepts

All Affiliations

Ionis Pharmaceuticals (United States)University of Colorado BoulderUniversity of Colorado HealthNovartis (Switzerland)University of Colorado Anschutz Medical Campus
HS

About

Henri Sasmor is an author at Ionis Pharmaceuticals (United States) specializing in molecular biology, natural sciences, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Natural Sciences

12

12

1.3K

2

Biochemistry

11

11

938

3

Medicine

6

6

658

4

Biomolecular Engineering

5

5

327

5

Engineering

3

3

211

Henri Sasmor

×

30

Publications

3.5K

Citations

23

H-Index

YearCitations

2′-O-(2-Methoxy)ethyl-modified Anti-intercellular Adhesion Molecule 1 (ICAM-1) Oligonucleotides Selectively Increase the ICAM-1 mRNA Level and Inhibit Formation of the ICAM-1 Translation Initiation Complex in Human Umbilical Vein Endothelial Cells

Brenda F. Baker, Sidney S. Lot, Thomas P. Condon,

Journal of Biological Chemistry

1997

374

Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats

Richard S. Geary, Tanya Watanabe, L Truong,

Journal of Pharmacology and Experimental Therapeutics

2001

280

Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats.

Paul A. Cossum, Henri Sasmor, D Dellinger,

Journal of Pharmacology and Experimental Therapeutics

1993

266

A perfectly symmetric lac operator binds the lac repressor very tightly.

John R. Sadler, Henri Sasmor, Joan L. Betz

Proceedings of the National Academy of Sciences

1983

264

Pharmacokinetic properties of several novel oligonucleotide analogs in mice.

Stanley T. Crooke, Melissa Graham, J E Zuckerman,

Journal of Pharmacology and Experimental Therapeutics

1996

228

Characterization of a Potent and Specific Class of Antisense Oligonucleotide Inhibitor of Human Protein Kinase C-α Expression

Robert A. McKay, Loren Miraglia, Lendell L. Cummins,

Journal of Biological Chemistry

1999

226

Oligodeoxynucleotides containing 2'-O-modified adenosine: Synthesis and effects on stability of DNA:RNA duplexes

Elena A. Lesnik, Charles J. Guinosso, Andrew M. Kawasaki,

Biochemistry

1993

201

Nuclease Resistance and Antisense Activity of Modified Oligonucleotides Targeted to Ha-

Brett P. Monia, Joseph F. Johnston, Henri Sasmor,

Journal of Biological Chemistry

1996

177

Second Generation of Antisense Oligonucleotides: From Nuclease Resistance to Biological Efficacy in Animals

Karl‐Heinz Altmann, Nicholas M. Dean, Doriano Fabbro,

CHIMIA International Journal for Chemistry

1996

173

PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES

Richard S. Geary, Rosie Z. Yu, Tanya Watanabe,

Drug Metabolism and Disposition

2003

162

Page 1